News Called to Account: Drug companies are making an accounting change after the SEC cracked down on Biogenon 06/05/2022 at 11:17 am 06/05/2022 0 Reporters and analysts covering first-quarter earnings from drug companies may have noticed a change in how they account for upfront payments made to finance research and development at companies in which they have acquired equity stakes. Related Tags: account, drug, financial news, news, trade Continue Reading Previous Earnings Results: WWE body-slams quarterly earnings with record revenueon 06/05/2022 at 1:00 amNext : Elon Musk pitch deck for Twitter promises to nearly triple ad revenue, create $10 billion subscription business: reporton 06/05/2022 at 11:40 pm More Stories News 3 top stocks for the second half of 2023on 04/07/2023 at 8:24 am 04/07/2023 0 News : Apple scaling back targets on Vision Pro headsets: reporton 03/07/2023 at 7:39 am 03/07/2023 0 News 3 FTSE 100 shares I’d buy as the economy slumps 10/04/2023 at 6:04 am 14/04/2023 0 Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.